Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Pittcon 2012 Releases Conference Summary

Published: Thursday, March 29, 2012
Last Updated: Thursday, March 29, 2012
Bookmark and Share
The Pittcon 2012 Organizing Committee announced that this year's conference and exposition for laboratory science attracted 15,754 attendees (conferees and exhibitor personnel) to the annual event.

The event, which was held in Orlando, Florida, March 11-15 also attracted twenty-nine percent of the conferees from 89 countries outside the United States.

Pittcon 2012 President Jon Peace commented, "In a time where economic changes, increased mergers and acquisitions, and rising travel costs have a substantial impact on conferences, attendees still consider Pittcon to be a most valuable educational and networking resource for the global scientific community."

The Exposition included 948 exhibiting companies occupying 1,854 booths showcasing their latest laboratory instrumentation, equipment and services across a broad range of applications and technologies used in laboratory science. There were 191 exhibiting companies (20%) from 28 countries outside of the United States. This year, Pittcon welcomed 119 (12.5%) first time exhibitors and recognized the following returning companies that participated at Sponsorship Level: ABSCIEX, Jasco, Millipore, Sigma-Aldrich, Shimadzu, and Thermo Fisher Scientific.

The comprehensive Technical Program included more than 2,000 individual presentations distributed among Invited Symposia, Organized Contributed Sessions, Achievement Awards, Workshops, and Poster presentations. More than 100 invited speakers addressed topics of global interest, including alternative and sustainable energy, homeland security, food and drug safety, environmental issues, new materials development, and bioanalytical techniques. Approximately 1,400 people attended the Plenary Lecture presented by R. Graham Cooks, and Steven Benner delivered the Capstone Lecture to an audience of 700.

The 2012 Short Course program offered 95 courses (16 of which were new) and drew approximately 1,400 registrants which was a 16% increase over 2011 attendance.

The Pittcon Employment Bureau registered 143 employers, 512 candidates, 444 positions, and 455 interviews for the week.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Pittcon Announces Recipients of the Editors’ Awards
Recipients include Texas Instruments (Gold), Waters (Silver) and ABSciex (Bronze).
Thursday, April 10, 2014
Scientific News
Breakthrough Flu Vaccine Inhibited by Pre-existing Antibodies
Universal truths – how existing antibodies are sabotaging the most promising new human flu vaccines.
Zika Vaccine Candidates Show Promise
Two experimental vaccines have shown promise against a major viral strain responsible for the Brazilian Zika outbreak.
NIH Begins Yellow Fever Vaccine Trial
NIH has initiated an early-stage clinical trial of a vaccine to protect against yellow fever.
Antibody Drug Shows Promise in HIV Treatment
Researchers are a step closer to an alternative HIV treatment that has the potential for lasting effects and less frequent dosing.
Flu Vaccine May Reduce Risk of Death For Type 2 Diabetes Patients
Researchers at Imperial College London have suggested that the vaccine may have substantial benefits for patients with long-term conditions.
Flu Vaccine May Reduce Death Risk of Type 2 Diabetes
New research suggests that a new flu vaccine may reduce probability of type 2 diabetes patients being hospitalised with stroke and heart failure.
Disrupting Tumour-Promotion in Humans
Researchers have modified an existing protein to represses a specific cancer-promoting ‘message’ within cells.
Protein Nanocages Could Improve Drug Design and Delivery
HHMI scientists have designed and built 10 large protein icosahedra that are similar to viral capsids that carry viral DNA.
Vaccine Strategy Targets Multiple Influenza Viruses
Scientists have identified vaccine-induced antibodies that can neutralize strains of influenza virus that infect humans.
Antibody-Based Drug for Multiple Sclerosis
New antibody-based drug paves the way for new strategies for controlling and treating multiple sclerosis.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!